129 related articles for article (PubMed ID: 36522164)
21. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
22. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
Klimas J; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
Cochrane Database Syst Rev; 2014 Dec; (12):CD009269. PubMed ID: 25470303
[TBL] [Abstract][Full Text] [Related]
23. Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis.
Kassai S; Pintér JN; Rácz J; Böröndi B; Tóth-Karikó T; Kerekes K; Gyarmathy VA
Harm Reduct J; 2017 Feb; 14(1):9. PubMed ID: 28187774
[TBL] [Abstract][Full Text] [Related]
24. Physical harm due to chronic substance use.
van Amsterdam J; Pennings E; Brunt T; van den Brink W
Regul Toxicol Pharmacol; 2013 Jun; 66(1):83-7. PubMed ID: 23542091
[TBL] [Abstract][Full Text] [Related]
25. Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting.
Dong H; Hayashi K; Milloy MJ; DeBeck K; Singer J; Wong H; Wood E; Kerr T
Drug Alcohol Depend; 2020 Jul; 212():108005. PubMed ID: 32370932
[TBL] [Abstract][Full Text] [Related]
26. New psychoactive substances in Eurasia: a qualitative study of people who use drugs and harm reduction services in six countries.
Kurcevič E; Lines R
Harm Reduct J; 2020 Nov; 17(1):94. PubMed ID: 33256747
[TBL] [Abstract][Full Text] [Related]
27. Problematic khat use as a possible risk factor for harmful use of other psychoactive substances: a mixed method study in Ethiopia.
Mihretu A; Teferra S; Fekadu A
Subst Abuse Treat Prev Policy; 2017 Nov; 12(1):47. PubMed ID: 29096691
[TBL] [Abstract][Full Text] [Related]
28. High Prevalence and Early Onsets: Legal and Illegal Substance Use in an Urban Cohort of Young Adults in Switzerland.
Quednow BB; Steinhoff A; Bechtiger L; Ribeaud D; Eisner M; Shanahan L
Eur Addict Res; 2022; 28(3):186-198. PubMed ID: 34864731
[TBL] [Abstract][Full Text] [Related]
29. "Something that actually works": Cannabis use among young people in the context of street entrenchment.
Paul B; Thulien M; Knight R; Milloy MJ; Howard B; Nelson S; Fast D
PLoS One; 2020; 15(7):e0236243. PubMed ID: 32722721
[TBL] [Abstract][Full Text] [Related]
30. The Use of Psychoactive Substances and Illegal Drugs in the Albanian Society.
Matua L; Muharremi G; Petrela E; Koçibelli M; Vyshka G; Xhemali B
Curr Drug Res Rev; 2019; 11(1):73-79. PubMed ID: 30070180
[TBL] [Abstract][Full Text] [Related]
31. An overview of the use of psychoactive substances among students at the University of Lille during the COVID-19 health crisis: Results of the PETRA study.
Carton L; Bastien A; Chérot N; Caron C; Deheul S; Cottencin O; Gautier S; Moreau-Crépeaux S; Dondaine T; Bordet R
Dialogues Clin Neurosci; 2023 Dec; 25(1):101-111. PubMed ID: 37837439
[TBL] [Abstract][Full Text] [Related]
32. New psychoactive substances in Taiwan: The current situation and initiative for rational scheduling.
Yu WJ; Cottler L; Li JH
J Food Drug Anal; 2021 Mar; 29(1):168-181. PubMed ID: 35696229
[TBL] [Abstract][Full Text] [Related]
33. The role of illicit, licit, and designer drugs in the traffic in Hungary.
Institóris L; Hidvégi E; Dobos A; Sija É; Kereszty ÉM; Tajti LB; Somogyi GP; Varga T
Forensic Sci Int; 2017 Jun; 275():234-241. PubMed ID: 28412575
[TBL] [Abstract][Full Text] [Related]
34. Typology of new psychoactive substance use among the general Australian population.
Sutherland R; Peacock A; Roxburgh A; Barratt MJ; Burns L; Bruno R
Drug Alcohol Depend; 2018 Jul; 188():126-134. PubMed ID: 29775956
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of psychoactive substances, alcohol, illicit drugs, and medicines, in Spanish drivers: a roadside study.
Gómez-Talegón T; Fierro I; González-Luque JC; Colás M; López-Rivadulla M; Javier Álvarez F
Forensic Sci Int; 2012 Nov; 223(1-3):106-13. PubMed ID: 22947432
[TBL] [Abstract][Full Text] [Related]
36. The Australian drug harms ranking study.
Bonomo Y; Norman A; Biondo S; Bruno R; Daglish M; Dawe S; Egerton-Warburton D; Karro J; Kim C; Lenton S; Lubman DI; Pastor A; Rundle J; Ryan J; Gordon P; Sharry P; Nutt D; Castle D
J Psychopharmacol; 2019 Jul; 33(7):759-768. PubMed ID: 31081439
[TBL] [Abstract][Full Text] [Related]
37. What the History of Drugs Can Teach Us About the Current Cannabis Legalization Process: Unfinished Business.
Adrian M
Subst Use Misuse; 2015; 50(8-9):990-1004. PubMed ID: 26361906
[TBL] [Abstract][Full Text] [Related]
38. Harms associated with psychoactive substances: findings of the UK National Drug Survey.
Morgan CJ; Muetzelfeldt L; Muetzelfeldt M; Nutt DJ; Curran HV
J Psychopharmacol; 2010 Feb; 24(2):147-53. PubMed ID: 19939875
[TBL] [Abstract][Full Text] [Related]
39. 'South Asian cocktail'--the concurrent use of opioids, benzodiazepines and antihistamines among injecting drug users in Nepal and associations with HIV risk behaviour.
Ojha SP; Sigdel S; Meyer-Thompson HG; Oechsler H; Verthein U
Harm Reduct J; 2014 May; 11():17. PubMed ID: 24886095
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
